早期宫颈癌开腹与微创根治性子宫切除术比较:一项两中心回顾性队列研究,并对普通型腺癌与腺鳞癌进行病理学复核
这项两中心回顾性队列纳入2007至2020年接受根治性子宫切除术的2009 FIGO IB1-IB2期普通型腺癌与腺鳞癌患者161例,比较微创与开腹手术的生存结局。微创组与开腹组总生存及3年无病生存率无显著差异,多因素分析中微创与更差无病生存无关,而宫旁病理浸润与更差无病生存相关。
要点
- 普通型腺癌与腺鳞癌患者总生存(P=0.241)与无病生存(P=0.156)无显著差异。
- 微创组与开腹组总生存(P=0.201)及3年无病生存率(87.9% vs 75.1%;P=0.184)相似。
- 多因素分析中宫旁病理浸润与更差无病生存相关(校正HR 3.41;95%CI 1.25-9.29;P=0.016)。
核心结论
- 早期宫颈普通型腺癌与腺鳞癌中,微创与开腹根治性子宫切除术的生存结局相当。
- 微创根治性子宫切除术并非不良预后因素,但宫旁病理浸润与更差无病生存显著相关。
研究设计与样本
- 两中心回顾性队列研究,自两中心宫颈癌队列中回顾性识别2007至2020年接受根治性子宫切除术的2009 FIGO IB1-IB2期患者。
- 按更新版世界卫生组织肿瘤分类进行病理学复核后,纳入普通型腺癌与腺鳞癌患者,共161例。
- 比较开腹手术与微创手术的临床病理特征及生存结局。
主要发现
- 普通型腺癌(n=136)与腺鳞癌(n=25)患者总生存(P=0.241)与无病生存(P=0.156)无显著差异。
- 微创根治性子宫切除术组(n=99)较开腹组(n=62)肿瘤更小(P<0.001)、宫旁病理浸润更少(P=0.001)、淋巴结转移更少(P<0.001)。
- 微创组与开腹组总生存(P=0.201)及3年无病生存率(87.9% vs 75.1%;P=0.184)相似。
- 多因素分析中,更差无病生存与微创无关(P=0.589),而与宫旁病理浸润相关(校正HR 3.41;95%CI 1.25-9.29;P=0.016)。
- 在普通型腺癌患者中观察到一致结果,微创与更差无病生存无关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare survival outcomes of minimally invasive surgery (MIS) and open surgery for radical hysterectomy (RH) in early cervical cancer patients with histologic subtypes of usual-type adenocarcinoma and adenosquamous carcinoma. METHODS: From two centers' cervical cancer cohorts, patients with 2009 FIGO stage IB1-IB2 who underwent RH between 2007 and 2020 were retrospectively identified. Patients with usual-type adenocarcinoma and adenosquamous carcinoma were included in the analysis after pathologic review according to the updated World Health Organization Classification of Tumors. Clinicopathologic characteristics and survival outcomes were compared in terms of open surgery or MIS. RESULTS: This study included 161 patients. No significant differences were noted in overall survival (OS; P = 0.241) and disease-free survival (DFS; P = 0.156) between patients with usual-type adenocarcinoma (n = 136) and those with adenosquamous carcinoma (n = 25). MIS RH group (n = 99) had a significantly smaller tumor size (P < 0.001), lesser pathologic parametrial invasion (P = 0.001), and lesser lymph node metastasis (P < 0.001) than open RH group (n = 62). MIS and open RH groups showed similar OS (P = 0.201) and 3-year DFS rate (87.9% vs. 75.1%; P = 0.184). In multivariate analysis, worse DFS was not associated with MIS (P = 0.589) but was associated with pathologic parametrial invasion (adjusted HR, 3.41; 95% CI, 1.25-9.29; P = 0.016). Consistent results were observed among patients with usual-type adenocarcinoma; MIS was not associated with worse DFS. CONCLUSIONS: Comparable survival outcomes were found for MIS and open RH in early-stage cervical usual-type adenocarcinoma and adenosquamous carcinoma. Although MIS RH was not a poor prognostic factor, pathologic parametrial invasion was significantly associated with worse DFS in cervical usual-type adenocarcinoma and adenosquamous carcinoma.
引用
- Kim Y, Kim SI, Kim H, et al. Open versus minimally invasive radical hysterectomy for early cervical cancer: A two-center retrospective cohort study with pathologic review of usual-type adenocarcinoma and adenosquamous carcinoma. Gynecol Oncol. 2022. PMID: 35970602. doi:10.1016/j.ygyno.2022.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。